SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-211844
Filing Date
2022-08-04
Accepted
2022-08-04 07:48:59
Documents
15
Period of Report
2022-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d383701d8k.htm   iXBRL 8-K 29414
2 EX-99.1 d383701dex991.htm EX-99.1 78010
7 GRAPHIC g383701dsp_5.jpg GRAPHIC 21514
  Complete submission text file 0001193125-22-211844.txt   312181

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tmb-20220804.xsd EX-101.SCH 3935
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20220804_def.xml EX-101.DEF 14137
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20220804_lab.xml EX-101.LAB 23510
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20220804_pre.xml EX-101.PRE 15163
9 EXTRACTED XBRL INSTANCE DOCUMENT d383701d8k_htm.xml XML 6654
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 221134751
SIC: 2834 Pharmaceutical Preparations